Su F - Search Results

1

Efficacy and safety of Anlotinib in combination with gemcitabine and cisplatin as a first-line treatment for recurrent or metastatic nasopharyngeal carcinoma: A single-arm clinical trial.

Xiao Z, Chen W, Du Y, Zeng F, Su F, Huang S, Qu S. Xiao Z, et al. Among authors: su f. Int J Cancer. 2025 Jan 18. doi: 10.1002/ijc.35340. Online ahead of print. Int J Cancer. 2025. PMID: 39825777

2

Efficacy and safety of margetuximab plus chemotherapy vs. trastuzumab plus chemotherapy in Chinese patients with pretreated HER2-positive advanced metastatic breast cancer: results from a randomized, open-label, multicenter, phase II bridging study.

Zhang Q, Ouyang Q, Li W, Chiu J, Yan M, Lu YS, Sun S, Li H, Du Y, Wang X, Sun T, Yin Y, Wang H, Ye F, Shen K, Wang J, Pan Y, Wang S, Yang J, Wu X, Dai MS, Cheng J, Teng Y, Su F, Wu X, He J, Fu P, Yang L, Xin Y, Wang X, Jiang Z. Zhang Q, et al. Among authors: su f. Transl Breast Cancer Res. 2022 Oct 31;3:31. doi: 10.21037/tbcr-22-35. eCollection 2022. Transl Breast Cancer Res. 2022. PMID: 38751523 Free PMC article.

3

Prognostic evaluation of system immune-inflammatory index and prognostic nutritional index in double expressor diffuse large B-cell lymphoma.

Su F, Lian K. Su F, et al. Open Med (Wars). 2023 Oct 17;18(1):20230819. doi: 10.1515/med-2023-0819. eCollection 2023. Open Med (Wars). 2023. PMID: 37873542 Free PMC article.

4

Prognostic Factors and Nomogram for Malignant Brainstem Ependymoma: A Population-Based Retrospective Surveillance, Epidemiology, and End Results Database Analysis.

Ji X, Yang S, Cheng D, Zhao W, Sun X, Su F. Ji X, et al. Among authors: su f. Cancer Med. 2025 Jan;14(2):e70564. doi: 10.1002/cam4.70564. Cancer Med. 2025. PMID: 39825478 Free PMC article.

5

Adsorption behavior of levofloxacin hydrochloride on non-degradable microplastics aging with H₂O₂.

Li Y, Wang Y, Yang S, Bao T, Su F, Qian J. Li Y, et al. Among authors: su f. Water Environ Res. 2025 Feb;97(2):e70021. doi: 10.1002/wer.70021. Water Environ Res. 2025. PMID: 39901449

6

Silybin A from Silybum marianum reprograms lipid metabolism to induce a cell fate-dependent class switch from triglycerides to phospholipids.

Koeberle SC, Thürmer M, Su F, Werner M, Grander J, Hofer L, Gollowitzer A, Xuan LL, Benscheid FJ, Bonyadi Rad E, Zarrelli A, Di Fabio G, Werz O, Romanucci V, Lupp A, Koeberle A. Koeberle SC, et al. Among authors: su f. Theranostics. 2025 Jan 6;15(5):2006-2034. doi: 10.7150/thno.99562. eCollection 2025. Theranostics. 2025. PMID: 39897559 Free PMC article.

7

Anti-PD-L1 envafolimab combined with anti-VEGF suvemcitug in pretreated solid tumors and hepatocellular carcinoma: an open-label phase II study with safety run-in stage.

Ma L, Zhang Y, Fang Y, Hao C, Fan Q, Jiang D, Lu L, Su F, Yang C, Liu Z, Tian J, Sun X, Sun S, Cheng Y. Ma L, et al. Among authors: su f. Invest New Drugs. 2025 Jan 30. doi: 10.1007/s10637-025-01506-x. Online ahead of print. Invest New Drugs. 2025. PMID: 39883265

8

Discussion on the mechanism of HER2 resistance in esophagogastric junction and gastric cancer in the era of immunotherapy.

Zhang Y, Fan W, Su F, Zhang X, Du Y, Li W, Gao Y, Hu W, Zhao J. Zhang Y, et al. Among authors: su f. Hum Vaccin Immunother. 2025 Dec;21(1):2459458. doi: 10.1080/21645515.2025.2459458. Epub 2025 Jan 28. Hum Vaccin Immunother. 2025. PMID: 39875210 Free PMC article. Review.

9

Unveiling an innovative sustainable blue resource-ecofriendly extraction technique towards a circular economy: Optimization of natural deep eutectic solvent and ultrasonication synergistic pathways for type-I collagen refined recovery from discarded fish scales.

Hamdi M, Wang D, Li S, Su F. Hamdi M, et al. Among authors: su f. Int J Biol Macromol. 2025 Jan 23;300:140296. doi: 10.1016/j.ijbiomac.2025.140296. Online ahead of print. Int J Biol Macromol. 2025. PMID: 39863201

10

High-throughput markerless pose estimation and home-cage activity analysis of tree shrew using deep learning.

Wang Y, Su F, Cong R, Liu M, Shan K, Li X, Zhu D, Wei Y, Dai J, Zhang C, Tian Y. Wang Y, et al. Among authors: su f. Animal Model Exp Med. 2025 Jan 23. doi: 10.1002/ame2.12530. Online ahead of print. Animal Model Exp Med. 2025. PMID: 39846430 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,635 results

Search Page

Filters